Seq #120 Thursday, 11 March 2004

10:15 AM-11:30 AM Hawaii Convention Center Exhibit Hall 1-2, Poster
Delivery Systems
 
1156  Liposomes - effective drug carrier to oral mucosa
M. PETELIN1, V. ERJAVEC2, Z. PAVLICA2, M. SENTJURC3, and U. SKALERIC4, 1University of Ljubljana, Slovenia, 2University of Ljubljana, Veterinary Faculty, Slovenia, 3Institute of Jozef Stefan, Ljubljana, Slovenia, 4Director, Center of Dental Research, Ljubljana, Slovenia
1157  Microencapsulated Free Radical Scavengers as Therapeutic Agents for Facial Trauma
D.M. HUBER, United States Army Dental Research Detachment, Great Lakes, IL, USA, J.R. AMMANN, USADRD, Great Lakes, IL, USA, and T.A.-N. KONG, Rutgers, State University of New Jersey, Piscataway, USA
1158  LC/MS/MS evaluation of clindamycin released from PLGA microspheres
J. MACHOLL1, J.R. AMMANN2, and S. PATEL1, 1United States Army Dental Research Detachment, Great Lakes, IL, USA, 2USADRD, Great Lakes, IL, USA
1159  Phase‡TClinical Trial Chemotherapy with Nedaplatin,Docetaxel and Fluorouracil
K. UCHIYAMA, H. IWABUCHI, E. SHIMOMURA, D. KOBAYASHI, R. WAKABAYASHI, T. YASUI, and S. SATOH, Tochigi National Hospital, utsunomiya, Japan
1160  Transfection of wit-3.0 accelerates wound contraction
A. LIN1, C. SUKOTJO2, K. SONG1, T. OGAWA3, B. WU3, G.T.-J. HUANG3, and I. NISHIMURA3, 1University of California - Los Angeles, Bioengineering Department, USA, 2University of California - Los Angeles Oral Biology Department, USA, 3UCLA School of Dentistry, Los Angeles, CA, USA
1161  Serum Flumazenil and Oxygen Saturation Levels: an Animal Model Comparison
W. TOMPKINS1, T.W. SWEATMAN2, J.H. UNKEL3, M. SCARBECZ1, M.M. RANDOLPH2, and A. FUNK2, 1University of Tennessee Health Science Center, College of Dentistry, Memphis, USA, 2University of Tennessee Health Science Center, College of Medicine, Memphis, USA, 3Virginia Commonwealth University - VCU/MCV, Richmond, USA
1162  Delivery of Anti-Bacterial Agents to Plaque from a Toothpaste
A.K. GREEN, P.J. HALL, C.P. HORAY, S. DEBRABANDER, A.M. LLOYD, P.J. ABRAHAM, and T.F. COX, Unilever Oral Care, Wirral, United Kingdom
1163  Evaluation of Hot-Melt Extruded Films Containing Antifungals for Oral Candidiasis
M.A. REPKA, S. PRODDUTURI, and S.P. STODGHILL, University of Mississippi, USA
1165  Characterization of an AP-2 Site in the InsP3R Gene Promoter
B. CHRZAN, State University of New York at Buffalo, USA, and P. BRADFORD, State University of New York - Buffalo, USA

Back to the: Pharmacology, Therapeutics, & Toxicology Program

Back to the IADR/AADR/CADR 82nd General Session (March 10-13, 2004)

Top Level Search